| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $718.25K | $136.20K | $282.79K | $53.82K | $73.27K |
| R&D | $382.83K | $23.38K | – | – | – |
| SG&A | $335.42K | $136.20K | $282.79K | $53.82K | $73.27K |
| Operating Income | -$718.25K | -$136.20K | -$282.79K | -$53.82K | -$73.27K |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$718.25K | -$136.20K | -$282.79K | -$53.82K | -$73.27K |
| EPS (basic) | -0.0180 | -0.0050 | -0.4600 | -0.0800 | – |
| EPS (diluted) | -0.0180 | -0.0050 | -0.4600 | -0.0800 | – |
| Shares (diluted) | $39.37M | $26.63M | $619.09K | $619.09K | – |